Monocytes stimulated with group B Streptococci or interferons release tumour necrosis factor-related apoptosis-inducing ligand

Scandinavian Journal of Immunology

Volumn 60, Issue 1, 2004, Pages 74-81

  Halaas, O ^a   Liabakk, N B ^a   Vik, R ^a   Beninati, C ^b   Henneke, P ^c   Sundan, A ^a   Espevik, T ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF MESSINA   (Italy)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETA INTERFERON; CYSTEINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; LIGAND; LIPOPOLYSACCHARIDE; METALLOPROTEINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MONOCYTE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; STREPTOCOCCUS AGALACTIAE; UPREGULATION;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; INTERFERONS; LEUCINE; LEUPEPTINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MONOCYTES; PROTEASE INHIBITORS; STREPTOCOCCUS AGALACTIAE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 3242663636     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01448.x     Document Type: Article

References (36)

1. Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-82.
2. Pitti RM, Marsters SA, Ruppert S et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996;271:12687-90.
3. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8.
4. Ashkenazi A, Pai RC, Fong S et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155-62.
5. Griffith TS, Wiley SR, Kubin MZ et al. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med 1999;189:1343-54.
6. Halaas Ø, Vik R, Ashkenazi A, Espevik T. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand J Immunol 2000;51:244-50.
7. Alexander EH, Bento JL, Hughes FM et al. Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumor necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts. Infect Immun 2001;69:1581-6.
8. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995;85:3378-404.
9. Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 1998;28:973-82.
10. Liabakk NB, Sundan A, Torp S et al. Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. J Immunol Methods 2002;259:119-28.
11. Martinez-Lorenzo MJ, Anel A, Gamen S et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 1999;163:1274-81.
12. Hymowitz SG, O'Connell MP, Ultsch MH et al. A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 2000;39:633-40.
13. Fettucciari K, Rosati E, Scaringi L et al. Group B Streptococcus induces apoptosis in macrophages. J Immunol 2000;165:3923-33.
14. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cytokines. J Immunol 1991;147:3408-12.
15. Mangan DF, Welch GR, Wahl SM. Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 1991;146:1541-6.
16. Swe M, Sit KH. zVAD-fmk and DEVD-cho induced late mitosis arrest and apoptotic expressions. Apoptosis 2000;5:29-36.
17. Strand BL, Ryan TL, In't VP et al. Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 2001;10:263-75.
18. Rosenberger CM, Scott MG, Gold MR, Hancock RE, Finlay BB. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol 2000;164:5894-904.
19. Santini SM, Lapenta C, Logozzi M et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 2000;191:1777-88.
20. Perera LP, Waldmann TA. Activation of human monocytes induces differential resistance to apoptosis with rapid down regulation of caspase-8/FLICE. Proc Natl Acad Sci USA 1998;95:14308-13.
21. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94.
22. Baetu TM, Kwon H, Sharma S, Grandvaux N, Hiscott J. Disruption of nf-kappab signaling reveals a novel role for nf-kappab in the regulation of TNF-related apoptosis-inducing ligand expression. J Immunol 2001;167:3164-73.
23. Siegmund D, Hausser A, Peters N, Scheurich P, Wajant H. Tumor necrosis factor and phorbol ester induce TRAIL under critical involvement of NEMO/IKKgamma. J Biol Chem 2001;276:43708-12.
24. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol 2000;12:419-24.
25. Vadiveloo PK, Vairo G, Hertzog P, Kola I, Hamilton JA. Role of type I interferons during macrophage activation by lipopolysaccharide. Cytokine 2000;12:1639-46.
26. Kalvakolanu DV, Borden EC. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest 1996;14:25-53.
27. Gusella GL, Musso T, Rottschafer SE, Pulkki K, Varesio L. Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma. J Immunol 1995;154:345-54.
28. McGeehan GM, Becherer JD, Bast Jr RC et al. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 1994;370:558-61.
29. Kayagaki N, Kawasaki A, Ebata T et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995;182:1777-83.
30. Martinez-Lorenzo MJ, Alava MA, Gamen S et al. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 1998;28:2714-25.
31. Monleon I, Martinez-Lorenzo MJ, Anel A et al. CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells. Eur J Immunol 2000;30:1078-87.
32. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 1997;186:2045-50.
33. Muhlenbeck F, Schneider P, Bodmer JL et al. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation. J Biol Chem 2000;275:32208-13.
34. Aoki K, Kurooka M, Chen JJ et al. Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity. Nat Immunol 2001;2:333-7.
35. Gearing AJ, Beckett P, Christodoulou M et al. Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol 1995;57:774-7.
36. Nakada-Tsukui K, Watanabe N, Kobayashi Y. Regulation of the processing and release of tumor necrosis factor alpha in a human macrophage cell line. J Leukoc Biol 1999;66:968-73.